Allakos Skin Drug Fails 2 Mid-Stage Tests, Sparks Restructuring to Cut 50% of Staff

Retrieved on: 2024-01-16 17:05:52

Tags for this article:

Hives

Type I hypersensitivity

Chronic spontaneous urticaria

Monoclonal antibodies

G protein-coupled receptors

Immunoglobulin E

ALLAKOS

Click the tags to see associated articles and topics

Allakos Skin Drug Fails 2 Mid-Stage Tests, Sparks Restructuring to Cut 50% of Staff. View article details on HISWAI: https://medcitynews.com/2024/01/allakos-skin-drug-inflammation-atopic-dermatitis-chronic-spontaneous-urticaria/

Excerpt

Allakos, atopic dermatitis, biopharma nl, chronic spontaneous urticaria, Clinical Trials, inflammation, san carlos. Hear the latest industry news ...

Article found on: medcitynews.com

View Original Article